Succimer
Succimer, sold under the brand name Chemet among others, is a medication used to treat lead, mercury, and arsenic poisoning. When radiolabeled with technetium-99m, it is used in many types of diagnostic testing. A full course of Succimer lasts for 19 days of oral administration. A second course should be given when more than two weeks pass after the first course.
Clinical data | |
---|---|
Pronunciation | /ˈsʌksɪmər/ |
Trade names | Chemet, others |
Other names | Dimercaptosuccinic acid DMSA (2R,3S)-2,3-Dimercaptosuccinic acid meso-2,3-Dimercaptosuccinic acid APRD01236 |
AHFS/Drugs.com | Monograph |
License data | |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.005.597 |
Chemical and physical data | |
Formula | C4H6O4S2 |
Molar mass | 182.21 g·mol−1 |
3D model (JSmol) | |
Melting point | 125 °C (257 °F) |
| |
|
Common side effects include vomiting, diarrhea, rash, and low blood neutrophil levels. Liver problems and allergic reactions may also occur with use. Whether use during pregnancy is safe for the baby is unclear. Dimercaptosuccinic acid is in the chelating agent family of medications. It works by binding with lead and a number of other heavy metals, allowing them to leave the body in the urine.
Succimer has been used medically since the 1950s. It is on the World Health Organization's List of Essential Medicines. In the United States, no generic version was available as of 2015.